Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$546,642,368
-$117,094,398 QoQ
Shares Held
5,807,930
-13.6% QoQ
Ownership
2.91%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.79955164748887.ToString("F0")%
Shared 0.ToString("F0")%
None 7.200448352511135.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,607,242,753 across 213 Biotechnology names. INCY ranks #3 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
This page
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $546,642,368 | 5,807,930 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $663,736,766 | 6,720,024 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $671,992,963 | 7,923,511 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $558,519,081 | 8,201,455 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $407,875,032 | 6,736,169 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $241,939,291 | 3,502,813 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $178,583,889 | 2,701,723 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $161,355,768 | 2,661,758 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $88,914,045 | 1,560,717 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $74,262,548 | 1,182,713 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $72,164,088 | 1,249,162 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $58,625,307 | 941,772 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $61,171,351 | 846,428 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $57,293,782 | 713,319 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $46,288,077 | 694,599 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $72,613,644 | 955,820 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $67,829,048 | 854,055 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $33,901,258 | 461,870 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $20,255,434 | 294,496 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,351,299 | 241,903 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,463,646 | 42,619 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,079,563 | 81,393 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $11,818,219 | 131,694 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $39,597,286 | 380,853 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $157,157,290 | 2,146,078 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||